BioAtla, Inc.
Pembelian

BCAB post earnings is set up LONG

Diupdate
BCAB a medical technology penny stock had a good beat on earnings. This means the cash

burn was only 70% of what was expected. On the strength of that traders reached. The

indicators suggest more upside including RSI lines crossing over the 50 level and the MACD

lines bouncing up on the approach to the zero horizontal line. The supply and demand curves

crossed. The Luxalgo predictive algorithm doing a pattern lookback analysis has a trend up.

I will take a long trade here attempting to get a good piece of the move for realized profit.
Catatan
Great price action today 25% off the position. Stop loss changed to 3% trailing. No risk trade is what I like holding 3 day weekend 75% remaining.
BCABGrowthLABUmedtechpennystockpennystockpillplaypennies4profitpostearningsplayVolatilityVolume

Pernyataan Penyangkalan